Research and Evidence

QEEG and PBM Case Studies • Publications • Links

The science behind iMediSync

Rapid advances in Artificial Intelligence continue to help improve brain measurement technology. Development and clinical trials of the iMediSync Medical Series are currently ongoing, in collaboration universities and hospitals in South Korea. Diagnosis and PBM treatment trials in areas like Alzheimer’s, coma recovery, stroke cognitive impairment, Parkinson’s, depression and brain age are in their final stage, and will become available to clinicians in Australasia in 2022. ADHD, PTSD and TBI are areas currently under earlier research stages.

A digital illustration of a human brain with a semi-transparent exterior, split into two hemispheres. The left side shows a circuit-like pattern representing technology, while the right side depicts a neural network with interconnected lines and nodes, symbolizing artificial intelligence and neural connections.
QEEG Case Study Sample: MCI

QEEG Case Study Sample: MCI

PBM Case Study Sample: Depression

PBM Case Study Sample: Depression